Literature DB >> 18328307

Venous thromboembolism in patients hospitalized with nephrotic syndrome.

Fadi Kayali1, Reiad Najjar, Firas Aswad, Fadi Matta, Paul D Stein.   

Abstract

PURPOSE: Whether pulmonary embolism in patients with the nephrotic syndrome is caused by deep venous thrombosis or renal vein thrombosis is controversial. To determine which is the likely cause of pulmonary embolism in patients with the nephrotic syndrome, we investigated data from the National Hospital Discharge Survey.
METHODS: The number of patients discharged from nonfederal short-stay hospitals in the United States with a diagnostic code of nephrotic syndrome, deep venous thrombosis, renal vein thrombosis, and pulmonary embolism was obtained using ICD-9-M (International Classification of Diseases, Ninth Revision, Clinical Modification) codes.
RESULTS: From 1979 to 2005, 925,000 patients were discharged from hospitals with the nephrotic syndrome and 898,253,000 patients did not have the nephrotic syndrome. With the nephrotic syndrome, 5000 (0.5%) had pulmonary embolism, 14,000 (1.5%) had deep venous thrombosis, and fewer than 5000 had renal vein thrombosis. The relative risk of pulmonary embolism comparing patients with the nephrotic syndrome to those who did not have it was 1.39, and the relative risk of deep venous thrombosis was 1.72. Among patients aged 18-39 years, the relative risk of deep venous thrombosis was 6.81. From 1991-2005, after venous ultrasound was generally available, the relative risk of deep venous thrombosis (all ages) was 1.77.
CONCLUSION: The nephrotic syndrome is a risk factor for venous thromboembolism. This is strikingly apparent in young adults. Renal vein thrombosis was uncommon. Therefore, pulmonary embolism, if it occurs, is likely to be due to deep venous thrombosis and not renal vein thrombosis.

Entities:  

Mesh:

Year:  2008        PMID: 18328307     DOI: 10.1016/j.amjmed.2007.08.042

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  34 in total

Review 1.  Nephrotic syndrome in adults.

Authors:  Richard P Hull; David J A Goldsmith
Journal:  BMJ       Date:  2008-05-24

Review 2.  Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms.

Authors:  Keattiyoat Wattanakit; Mary Cushman
Journal:  Curr Opin Pulm Med       Date:  2009-09       Impact factor: 3.155

3.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

4.  The uremic solute-AHR-tissue factor axis in vascular cells, mouse models and thrombosis in chronic kidney disease patients.

Authors:  Nigel Mackman; Jonathan H Erlich
Journal:  Ann Transl Med       Date:  2018-06

5.  Glomerular Filtration Rate as a Prognostic Factor for Long-Term Mortality after Acute Pulmonary Embolism.

Authors:  Valdis Ģībietis; Dana Kigitoviča; Barbara Vītola; Sintija Strautmane; Andris Skride
Journal:  Med Princ Pract       Date:  2019-02-04       Impact factor: 1.927

6.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

7.  Chronic kidney disease and venous thromboembolism: a prospective study.

Authors:  Aaron R Folsom; Pamela L Lutsey; Brad C Astor; Keattiyoat Wattanakit; Susan R Heckbert; Mary Cushman
Journal:  Nephrol Dial Transplant       Date:  2010-03-29       Impact factor: 5.992

8.  Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

Authors:  Taewoo Lee; Andrea K Biddle; Sofia Lionaki; Vimal K Derebail; Sean J Barbour; Sameer Tannous; Michelle A Hladunewich; Yichun Hu; Caroline J Poulton; Shannon L Mahoney; J Charles Jennette; Susan L Hogan; Ronald J Falk; Daniel C Cattran; Heather N Reich; Patrick H Nachman
Journal:  Kidney Int       Date:  2013-12-11       Impact factor: 10.612

9.  Pulmonary embolism revealing idiopathic membranous glomerulonephritis.

Authors:  A Hamzaoui; O Harzallah; R Klii; L Njim; S Mahjoub
Journal:  Case Rep Med       Date:  2010-09-20

10.  Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?

Authors:  Marco Zaffanello; Milena Brugnara; Vassilios Fanos; Massimo Franchini
Journal:  Int Urol Nephrol       Date:  2008-08-12       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.